ZA989204B - Halogen substituted tetracyclic tetrahydrofuran derivatives. - Google Patents
Halogen substituted tetracyclic tetrahydrofuran derivatives.Info
- Publication number
- ZA989204B ZA989204B ZA9809204A ZA989204A ZA989204B ZA 989204 B ZA989204 B ZA 989204B ZA 9809204 A ZA9809204 A ZA 9809204A ZA 989204 A ZA989204 A ZA 989204A ZA 989204 B ZA989204 B ZA 989204B
- Authority
- ZA
- South Africa
- Prior art keywords
- halogen substituted
- tetrahydrofuran derivatives
- substituted tetracyclic
- tetracyclic tetrahydrofuran
- derivatives
- Prior art date
Links
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 title 1
- 125000005843 halogen group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97203154 | 1997-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA989204B true ZA989204B (en) | 2000-04-10 |
Family
ID=8228817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9809204A ZA989204B (en) | 1997-10-10 | 1998-10-08 | Halogen substituted tetracyclic tetrahydrofuran derivatives. |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US6511976B1 (fr) |
| EP (1) | EP1021432B1 (fr) |
| JP (1) | JP3248902B2 (fr) |
| KR (1) | KR100366014B1 (fr) |
| CN (1) | CN100340554C (fr) |
| AP (1) | AP1239A (fr) |
| AR (1) | AR017325A1 (fr) |
| AT (1) | ATE235479T1 (fr) |
| AU (1) | AU737334B2 (fr) |
| BG (1) | BG64387B1 (fr) |
| BR (1) | BR9812871A (fr) |
| CA (1) | CA2305612C (fr) |
| CZ (1) | CZ296928B6 (fr) |
| DE (1) | DE69812668T2 (fr) |
| DK (1) | DK1021432T3 (fr) |
| EA (1) | EA003698B1 (fr) |
| EE (1) | EE04526B1 (fr) |
| ES (1) | ES2195403T3 (fr) |
| HK (1) | HK1029106A1 (fr) |
| HR (1) | HRP20000189A2 (fr) |
| HU (1) | HU225161B1 (fr) |
| ID (1) | ID23903A (fr) |
| IL (1) | IL135538A (fr) |
| MY (1) | MY117783A (fr) |
| NO (1) | NO317159B1 (fr) |
| NZ (1) | NZ503294A (fr) |
| OA (1) | OA11898A (fr) |
| PL (1) | PL339833A1 (fr) |
| PT (1) | PT1021432E (fr) |
| SI (1) | SI1021432T1 (fr) |
| SK (1) | SK284028B6 (fr) |
| TR (1) | TR200000918T2 (fr) |
| TW (1) | TW567186B (fr) |
| UA (1) | UA52778C2 (fr) |
| WO (1) | WO1999019317A1 (fr) |
| ZA (1) | ZA989204B (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| JP4516752B2 (ja) * | 2001-12-07 | 2010-08-04 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | トランス−縮合３，３ａ，８，１２ｂ−テトラヒドロ−２Ｈ−ジベンゾ［３，４：６，７］シクロヘプタ［１，２−ｂ］フラン誘導体の製造法 |
| IL162350A0 (en) * | 2001-12-07 | 2005-11-20 | Janssen Pharmaceutica Nv | Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives |
| HRP20020305A8 (en) * | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| HRP20020441A2 (en) * | 2002-05-21 | 2003-12-31 | Pliva D D | 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof |
| HRP20030160A2 (en) * | 2003-03-06 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | 1-thiadibenzoazulene derivatives and biological action thereof |
| HRP20030885A2 (en) * | 2003-11-03 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS |
| HRP20030954A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva D.D. | USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030953A2 (en) * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030958A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030956A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU |
| HRP20030955A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030959A2 (fr) * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | |
| HRP20030957A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20040104A2 (en) * | 2004-01-30 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| ATE402932T1 (de) * | 2004-06-14 | 2008-08-15 | Janssen Pharmaceutica Nv | Neue tetracyclische tetrahydrofuranderivate |
| CA2568752C (fr) * | 2004-06-23 | 2013-05-07 | Janssen Pharmaceutica N.V. | Nouveaux derives de tetrahydrofurane tetracycliques insatures |
| WO2006061392A2 (fr) | 2004-12-07 | 2006-06-15 | Janssen Pharmaceutica N.V. | Nouveaux derives insatures tetracycliques de tetrahydrofurane, pyrrolidine et tetrahydrothiophene |
| AU2011202995B2 (en) * | 2004-12-07 | 2012-02-02 | Janssen Pharmaceutica N.V. | Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| CA2595170C (fr) | 2005-01-27 | 2014-08-05 | Janssen Pharmaceutica N.V. | Derives heterocycliques tetracycliques de tetrahydrofuranne en tant qu'inhibiteurs de 5ht2 dans le traitement de troubles du systeme nerveux central |
| NZ562724A (en) | 2005-05-19 | 2010-07-30 | Janssen Pharmaceutica Nv | Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| WO2006125812A1 (fr) * | 2005-05-26 | 2006-11-30 | Janssen Pharmaceutica N.V. | Nouveaux derives de tetrahydrothiophene, pyrolidine et tetrahydrofurane tetracyclique substitues et leur utilisation en tant que medicament |
| ES2342110T3 (es) * | 2005-06-17 | 2010-07-01 | Janssen Pharmaceutica Nv | Nuevos derivados tetraciclicos de tetrahidrofurano que contienen una cadena lateral de amina ciclica. |
| US9125866B1 (en) | 2015-01-28 | 2015-09-08 | King Saud University | Antidepressant compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552399A (en) | 1994-11-02 | 1996-09-03 | Janssen Pharmaceutica N.V. | Substituted tetracyclic azepine derivatives |
| US5773433A (en) * | 1994-11-02 | 1998-06-30 | Janssen Pharmaceutica, N.V. | Substituted tetracyclic oxazepine and thiazepine derivatives |
| US6057441A (en) * | 1996-04-12 | 2000-05-02 | Janssen Pharmaceutica, N.V. | Substituted tetracyclic tetrahydrofuran derivatives |
| CA2264267A1 (fr) | 1996-08-28 | 1998-03-05 | Michael Edward Flaugh | 1,2,3,4-tetrahydro-2-dibenzofuranamines substitues et 2-aminocyclo-hepta¬b|benzofuranes |
-
1998
- 1998-06-10 UA UA2000041945A patent/UA52778C2/uk unknown
- 1998-10-06 AP APAP/P/2000/001784A patent/AP1239A/en active
- 1998-10-06 DK DK98950107T patent/DK1021432T3/da active
- 1998-10-06 AU AU96296/98A patent/AU737334B2/en not_active Ceased
- 1998-10-06 SI SI9830430T patent/SI1021432T1/xx unknown
- 1998-10-06 BR BR9812871-0A patent/BR9812871A/pt not_active Application Discontinuation
- 1998-10-06 EP EP98950107A patent/EP1021432B1/fr not_active Expired - Lifetime
- 1998-10-06 MY MYPI98004563A patent/MY117783A/en unknown
- 1998-10-06 CA CA002305612A patent/CA2305612C/fr not_active Expired - Fee Related
- 1998-10-06 EE EEP200000161A patent/EE04526B1/xx not_active IP Right Cessation
- 1998-10-06 PT PT98950107T patent/PT1021432E/pt unknown
- 1998-10-06 OA OA00000105A patent/OA11898A/en unknown
- 1998-10-06 US US09/529,252 patent/US6511976B1/en not_active Expired - Fee Related
- 1998-10-06 PL PL98339833A patent/PL339833A1/xx not_active IP Right Cessation
- 1998-10-06 DE DE69812668T patent/DE69812668T2/de not_active Expired - Lifetime
- 1998-10-06 SK SK471-2000A patent/SK284028B6/sk unknown
- 1998-10-06 IL IL13553898A patent/IL135538A/xx not_active IP Right Cessation
- 1998-10-06 CN CNB98809956XA patent/CN100340554C/zh not_active Expired - Fee Related
- 1998-10-06 EA EA200000400A patent/EA003698B1/ru not_active IP Right Cessation
- 1998-10-06 WO PCT/EP1998/006352 patent/WO1999019317A1/fr active IP Right Grant
- 1998-10-06 TR TR2000/00918T patent/TR200000918T2/xx unknown
- 1998-10-06 HU HU0003748A patent/HU225161B1/hu not_active IP Right Cessation
- 1998-10-06 NZ NZ503294A patent/NZ503294A/en not_active IP Right Cessation
- 1998-10-06 AT AT98950107T patent/ATE235479T1/de active
- 1998-10-06 CZ CZ20001136A patent/CZ296928B6/cs not_active IP Right Cessation
- 1998-10-06 JP JP2000515890A patent/JP3248902B2/ja not_active Expired - Fee Related
- 1998-10-06 ID IDW20000646A patent/ID23903A/id unknown
- 1998-10-06 ES ES98950107T patent/ES2195403T3/es not_active Expired - Lifetime
- 1998-10-06 KR KR1020007001926A patent/KR100366014B1/ko not_active IP Right Cessation
- 1998-10-08 ZA ZA9809204A patent/ZA989204B/xx unknown
- 1998-10-09 TW TW087116681A patent/TW567186B/zh not_active IP Right Cessation
- 1998-10-09 AR ARP980105055A patent/AR017325A1/es unknown
-
2000
- 2000-03-30 BG BG104287A patent/BG64387B1/bg unknown
- 2000-04-05 HR HR20000189A patent/HRP20000189A2/hr not_active Application Discontinuation
- 2000-04-06 NO NO20001792A patent/NO317159B1/no not_active IP Right Cessation
- 2000-11-10 HK HK00107164A patent/HK1029106A1/xx not_active IP Right Cessation
-
2002
- 2002-11-12 US US10/292,270 patent/US6699858B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA989204B (en) | Halogen substituted tetracyclic tetrahydrofuran derivatives. | |
| ZA988078B (en) | Substituted oxindole derivatives. | |
| ZA9811599B (en) | Ortho-anthranilamide derivatives as anti-coagulants. | |
| ZA200203581B (en) | Bicyclic imidazo-3-yl-amine derivatives. | |
| AP9701077A0 (en) | Substituted 6,5-hetero bicyclic derivatives | |
| AP9701076A0 (en) | Substituted 6,6-hetero bicyclic derivatives | |
| ZA982853B (en) | Nicotinamide derivatives. | |
| ZA99254B (en) | Benzosulfone derivatives. | |
| ZA200007593B (en) | Quinoline Derivatives. | |
| HK1018216A1 (en) | New 19-nor-pregnene derivatives. | |
| ZA986905B (en) | Substituted quinazoline derivatives. | |
| SG71077A1 (en) | 8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives | |
| HU9700126D0 (en) | 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives | |
| HK1018457A1 (en) | Alkylaminobenzothiazole and-benzoxazole derivatives. | |
| IL126624A0 (en) | 3-descladinose-2, 3-anhydroerythromycin derivatives | |
| ZA987055B (en) | Substituted 4-benzoylpyrazoles. | |
| ZA987058B (en) | Substituted 4-benzoylpyrazoles. | |
| ZA991550B (en) | Cyclohexanediole derivatives. | |
| ZA974953B (en) | Substituted pyrazolylpyrazole derivatives. | |
| HK1040991A1 (zh) | 2-雜芳基-3，4-二氫-2h-吡咯衍生物 | |
| HK1043119A1 (en) | Chroman derivatives. | |
| ZA982436B (en) | Thiazolimine derivatives. | |
| ZA987B (en) | Substituted 4-benzoylpyrazoles. | |
| ZA971167B (en) | Heterocyclyl-ergoline derivatives. | |
| CY2322B1 (en) | Benzoaeguequinoline derivatives. |